K031565

Substantially Equivalent

XPECT INFLUENZA A/B

Applicant: Remel, Inc.
Product code: PSZ
Advisory panel: Microbiology
Date received: 2003-05-19
Decision date: 2003-07-17
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Lenexa, KS, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.